MYW-13700-72120
2 vaccinations
2 coded responses
7 check-ins
2 free-text entries
1 call case
- Sex
- Female
- Age at first dose
- 26-30
- ZIP prefix
- 765 / TX
- Registered
- 2021-03-09
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-02-12
Dose 1 — Pfizer-BioNTech
-
2021-03-04
Dose 2 — Pfizer-BioNTech
-
2021-03-09
Registered in v-safe
-
2021-03-09
Survey response — days 1–6 daily, dose 2MedDRA: No adverse event — Feeling: GoodFree text: No symptoms from either doseMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-03-10
- 2021-03-11
- 2021-03-25
- 2021-04-01
- 2021-06-03
-
2021-09-04
Survey response — 6 months, dose 2MedDRA: Office visit, Pregnancy — Feeling: Good · Get care from a doctor or other healthcare professionalFree text: Symptoms: I became pregnant. · Healthcare visit (other): OBGYNMedDRA releases: 2021-09,2024-11 · check-in free text available
-
2021-09-04
Report sent to call center — 6 months, dose 2Get care from a doctor or other healthcare professional1 call case(s)
- 2021-09-07
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-02-12 | Pfizer-BioNTech | |
| 2 | 2021-03-04 | Pfizer-BioNTech |
Call center
1 call center case
1 unsuccessful
Free text
Release 5 — days 1–6 daily, dose 2
Systemic reaction (other): No symptoms from either dose
Release 9 — 6 months, dose 2
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| HCVO | Office visit | ✓ | · | ✓ |
| SD | Pregnancy | ✓ | · | ✓ |
| SRO | No adverse event | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release